150 related articles for article (PubMed ID: 37195263)
21. hRAD30 mutations in the variant form of xeroderma pigmentosum.
Johnson RE; Kondratick CM; Prakash S; Prakash L
Science; 1999 Jul; 285(5425):263-5. PubMed ID: 10398605
[TBL] [Abstract][Full Text] [Related]
22. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
23. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
24. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
Lambert WC; Lambert MW
Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
[TBL] [Abstract][Full Text] [Related]
25. Skin cancer and chromosomal aberrations induced by ultraviolet radiation. Evidence for lack of correlation in xeroderma pigmentosum variant and group E patients.
Seguin LR; Ganges MB; Tarone RE; Robbins JH
Cancer Genet Cytogenet; 1992 Jun; 60(2):111-6. PubMed ID: 1606553
[TBL] [Abstract][Full Text] [Related]
26. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
27. Abnormal, error-prone bypass of photoproducts by xeroderma pigmentosum variant cell extracts results in extreme strand bias for the kinds of mutations induced by UV light.
McGregor WG; Wei D; Maher VM; McCormick JJ
Mol Cell Biol; 1999 Jan; 19(1):147-54. PubMed ID: 9858539
[TBL] [Abstract][Full Text] [Related]
28. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
[TBL] [Abstract][Full Text] [Related]
29. Translesion replication in cisplatin-treated xeroderma pigmentosum variant cells is also caffeine-sensitive: features of the error-prone DNA polymerase(s) involved in UV-mutagenesis.
Yamada K; Takezawa J; Ezaki O
DNA Repair (Amst); 2003 Aug; 2(8):909-24. PubMed ID: 12893087
[TBL] [Abstract][Full Text] [Related]
30. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N
J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439
[TBL] [Abstract][Full Text] [Related]
31. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
Sugasawa K
Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
[TBL] [Abstract][Full Text] [Related]
32. Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts.
Wang YC; Maher VM; Mitchell DL; McCormick JJ
Mol Cell Biol; 1993 Jul; 13(7):4276-83. PubMed ID: 8321229
[TBL] [Abstract][Full Text] [Related]
33. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
34. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
35. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
36. Efficient repair of cyclobutane pyrimidine dimers at mutational hot spots is restored in complemented Xeroderma pigmentosum group C and trichothiodystrophy/xeroderma pigmentosum group D cells.
Zhou NY; Bates SE; Bouziane M; Stary A; Sarasin A; O'Connor TR
J Mol Biol; 2003 Sep; 332(2):337-51. PubMed ID: 12948486
[TBL] [Abstract][Full Text] [Related]
37. UV-induced mutations in epidermal cells of mice defective in DNA polymerase η and/or ι.
Kanao R; Yokoi M; Ohkumo T; Sakurai Y; Dotsu K; Kura S; Nakatsu Y; Tsuzuki T; Masutani C; Hanaoka F
DNA Repair (Amst); 2015 May; 29():139-46. PubMed ID: 25733082
[TBL] [Abstract][Full Text] [Related]
38. Shining a light on xeroderma pigmentosum.
DiGiovanna JJ; Kraemer KH
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
[TBL] [Abstract][Full Text] [Related]
39. DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide.
Latancia MT; Moreno NC; Leandro GS; Ribeiro VC; de Souza I; Vieira WKM; Bastos AU; Hoch NC; Rocha CRR; Menck CFM
Mutat Res Genet Toxicol Environ Mutagen; 2022 Jun; 878():503498. PubMed ID: 35649682
[TBL] [Abstract][Full Text] [Related]
40. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]